Mucocutaneous Manifestations of Covid-19 in an Isolation Unit of Peshawar, Khyber Pakhtunkhwa
DOI:
https://doi.org/10.37762/jgmds.10-1.374Keywords:
COVID 19, Mucocutaneous ManifestationsAbstract
OBJECTIVES
This study aimed to determine the frequency of mucocutaneous manifestations in patients with COVID-19.
METHODOLOGY
This prospective cross-sectional study was conducted in the isolation ward of Hayatabad Medical Complex, Peshawar, for COVID-19-positive patients from 20th June to 30th July 2020. One hundred and twenty COVID-19-positive patients were included in our study. Patients fulfilling the inclusion criteria were subjected to a detailed clinical history and mucocutaneous and systemic examination. Relevant investigations were done. Data was recorded in predesigned proforma and analyzed for various statistical variables.
RESULTS
Among 120 patients included in our study, 87 were male and 33 female. Most patients belonged to the age group 21-40 years. A total of 17 patients showed mucocutaneous manifestations. Generalized pruritus and petechial rash were the most common, and the maculopapular rash were the least common. Mucosal involvement was seen in 2 patients.
CONCLUSION
Mucocutaneous manifestations are essential clues in the diagnosis of COVID-19. Early recognition may help in the effective management of patients
Downloads
Metrics
References
Tang K, Wang Y, Zhang H, Zheng Q, Fang R, Sun Q. Cutaneous manifestations of the Coronavirus Disease 2019 (COVID-19): A brief review. Dermatologic therapy. 2020 Jul;33(4):e13528–e13528
Sachdeva M, Gianotti R, Shah M, Bradanini L, Tosi D, Veraldi S, et al. Cutaneous manifestations of COVID-19: Report of three cases and a review of literature. Journal of dermatological science. 2020 May;98(2):75–81
Jia JL, Kamceva M, Rao SA, Linos E. Cutaneous manifestations of COVID-19: a preliminary review. Journal of the American Academy of Dermatology. 2020 Aug;83(2):687
Gianotti R, Zerbi P, Dodiuk-Gad RP. Clinical and histopathological study of skin dermatoses in patients affected by COVID-19 infection in the Northern part of Italy. Journal of dermatological science. 2020 May;98(2):141–3
Rahimi H, Tehranchinia Z. A Comprehensive Review of Cutaneous Manifestations Associated with COVID-19. BioMed research international. 2020 Jul 5;2020:1236520–1236520
Suchonwanit P, Leerunyakul K, Kositkuljorn C. Cutaneous manifestations in COVID-19: Lessons learned from current evidence. Journal of the American Academy of Dermatology. 2020 Jul;83(1):e57–60
Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases. Translational research : the journal of laboratory and clinical medicine. 2020 Jun;220:1–13
Recalcati S. Cutaneous manifestations in COVID‐19: a first perspective. Journal of the European Academy of Dermatology and Venereology [Internet]. 2020 May;34(5). Available from: http://dx.doi.org/10.1111/jdv.16387
Marzano AV, Genovese G. Response to: “Reply to ‘Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients: To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out.” Journal of the American Academy of Dermatology. 2020 Sep;83(3):e255–6
Amorim Dos Santos J, Normando AGC, Carvalho da Silva RL, De Paula RM, Cembranel AC, Santos-Silva AR, et al. Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations? International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020 Aug;97:326–8
Cebeci Kahraman F, Çaşkurlu H. Mucosal involvement in a COVID-19-positive patient: A case report. Dermatologic therapy. 2020 Jul;33(4):e13797–e13797
Cao Y, Li L, Feng Z, Wan S, Huang P, Sun X, et al. Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell discovery. 2020 Feb 24;6:11–11
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet (London, England). 2020 Feb 22;395(10224):565–74
Bwire GM. Coronavirus: Why Men are More Vulnerable to Covid-19 Than Women? SN comprehensive clinical medicine. 2020;2(7):874–6
Davies NG, Klepac P, Liu Y, Prem K, Jit M, Eggo RM. Age-dependent effects in the transmission and control of COVID-19 epidemics [Internet]. Cold Spring Harbor Laboratory; 2020
Stefaniak AA, Białynicki-Birula R, Krajewski PK, Matusiak Ł, Goldust M, Szepietowski JC. Itch in the era of COVID-19 pandemic: An unfolding scenario. Dermatologic therapy. 2020 Sep;33(5):e13477–e13477
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England). 2020 Feb 15;395(10223):497–506
Erbaş GS, Botsali A, Erden N, Arı C, Taşkın B, Alper S, et al. COVID-19-related oral mucosa lesions among confirmed SARS-CoV-2 patients: a systematic review. International journal of dermatology. 2022 Jan;61(1):20–32
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Abdur Rahim Khan, Farah Gul, Durdana Jalal, Iqbal Haider, Hamza Ali Khan
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
